Your browser doesn't support javascript.
loading
Evasion of NKG2D-mediated cytotoxic immunity by sarbecoviruses.
Hartmann, Jordan A; Cardoso, Marcella R; Talarico, Maria Cecilia Ramiro; Kenney, Devin J; Leone, Madison R; Reese, Dagny C; Turcinovic, Jacquelyn; O'Connell, Aoife K; Gertje, Hans P; Marino, Caitlin; Ojeda, Pedro E; De Paula, Erich V; Orsi, Fernanda A; Velloso, Licio Augusto; Cafiero, Thomas R; Connor, John H; Ploss, Alexander; Hoelzemer, Angelique; Carrington, Mary; Barczak, Amy K; Crossland, Nicholas A; Douam, Florian; Boucau, Julie; Garcia-Beltran, Wilfredo F.
Afiliação
  • Hartmann JA; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Cardoso MR; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • Talarico MCR; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • Kenney DJ; Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Leone MR; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • Reese DC; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Turcinovic J; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • O'Connell AK; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Gertje HP; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Marino C; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • Ojeda PE; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA.
  • De Paula EV; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil.
  • Orsi FA; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil.
  • Velloso LA; School of Medical Sciences, University of Campinas, Campinas, SP, Brazil; Obesity and Comorbidities Research Center, University of Campinas, Campinas, SP, Brazil.
  • Cafiero TR; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Connor JH; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Ploss A; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.
  • Hoelzemer A; First Department of Medicine, Division of Infectious Diseases, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Institute for Infection and Vaccine Development (IIRVD), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany; Research Department Virus Immunology, Leib
  • Carrington M; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Barczak AK; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Crossland NA; Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA; Department of Pathology and Laboratory Medicine, Boston University Chobanian &a
  • Douam F; Department of Virology, Immunology, and Microbiology, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA.
  • Boucau J; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA. Electronic address: jboucau@mgh.harvard.edu.
  • Garcia-Beltran WF; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: wgarciabeltran@mgh.harvard.edu.
Cell ; 187(10): 2393-2410.e14, 2024 May 09.
Article em En | MEDLINE | ID: mdl-38653235
ABSTRACT
SARS-CoV-2 and other sarbecoviruses continue to threaten humanity, highlighting the need to characterize common mechanisms of viral immune evasion for pandemic preparedness. Cytotoxic lymphocytes are vital for antiviral immunity and express NKG2D, an activating receptor conserved among mammals that recognizes infection-induced stress ligands (e.g., MIC-A/B). We found that SARS-CoV-2 evades NKG2D recognition by surface downregulation of MIC-A/B via shedding, observed in human lung tissue and COVID-19 patient serum. Systematic testing of SARS-CoV-2 proteins revealed that ORF6, an accessory protein uniquely conserved among sarbecoviruses, was responsible for MIC-A/B downregulation via shedding. Further investigation demonstrated that natural killer (NK) cells efficiently killed SARS-CoV-2-infected cells and limited viral spread. However, inhibition of MIC-A/B shedding with a monoclonal antibody, 7C6, further enhanced NK-cell activity toward SARS-CoV-2-infected cells. Our findings unveil a strategy employed by SARS-CoV-2 to evade cytotoxic immunity, identify the culprit immunevasin shared among sarbecoviruses, and suggest a potential novel antiviral immunotherapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Subfamília K de Receptores Semelhantes a Lectina de Células NK / Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Cell Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Subfamília K de Receptores Semelhantes a Lectina de Células NK / Evasão da Resposta Imune / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Revista: Cell Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos